On November 22, 2024, Claudia Poccia, a Director at Innospec Inc (IOSP, Financial), sold 300 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now owns 3,879 shares of the company.
Innospec Inc (IOSP) is a global specialty chemicals company with a focus on fuel specialties, oilfield services, and performance chemicals. The company provides innovative solutions to improve fuel efficiency, enhance oilfield productivity, and deliver high-performance chemicals for various industries.
The insider transaction history for Innospec Inc shows a total of 3 insider buys and 14 insider sells over the past year. This indicates a trend of more selling activity among insiders.
On the day of Claudia Poccia’s recent sale, shares of Innospec Inc were trading at $119.88, giving the stock a market cap of $2,991.745 million. The company's price-earnings ratio stands at 20.93, which is lower than the industry median of 24.78 but higher than the company’s historical median price-earnings ratio.
With a trading price of $119.88 and a GF Value of $109.17, Innospec Inc has a price-to-GF-Value ratio of 1.1, indicating that the stock is fairly valued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor and future business performance estimates from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
